Indian Pharma is their ability to retain their cost advantage while matching the quality standards of the West. But lower costs are not the only USP. Availability of skilled manpower and a favorable regulatory environment that assures compliance with global norms are the other two legs underpinning success. With a growing skill set and capacity in contract research (from combinatorial chemistry to high throughput screening, assay development and validation to clinical trials) and contract manufacturing, Indian companies are increasingly becoming preferred partners for Western bio-pharmaceutical companies seeking to bring their products to the market in a timely and cost-effective manner. India already boasts of more USFDA GMP approved API facilities than any other nation other than US. |